Japan stock market week to March 2, 2009

9 March 2009

Tokyo experienced a losing streak for the third week in the review  period ended March 2. The Nikkei 225 was off 1.3%, closing at the 7,200  level, while the Topix index inched down 0.1%. The first four sessions  saw relatively firm movement backed by the weaker yen against major  currencies, which encouraged investors to buy back export-oriented  issues. However, the market nose-dived on the last trading day amid  pessimism regarding the global economic outlook and the financial  industry in the USA, with New York markets sinking to historic lows.  Active early-week purchasing was reportedly related to establishment of  some investment trust funds and moves for "window-dressing" by  investment funds trying to make their portfolios look favorable at the  end of the financial year. The pharmaceutical index dropped 3.9%,  underperforming the market.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Company News Directory



Companies featured in this story

More ones to watch >






Company Spotlight